Abstract
Objectives
To evaluate the prognostic ability of serum ferritin when estimated within 5 days of onset of illness in children with severe sepsis admitted to a pediatric intensive care unit.
Methods
This observational study enrolled children aged 1 month to 12 years with severe sepsis. Hemoglobin, serum ferritin and C-reactive protein levels were measured within five days of illness. Final outcomes were recorded in all enrolled children.
Results
70 children with median (IQR) age of 27 (8,108) months were enrolled during the study period (July, 2019 to August, 2021). 28 (40%) of these had poor outcome (nonsurvival). The median (IQR) level of serum ferritin was 1369 (558–5607) ng/mL in non-survivors and 282 (129–680) ng/mL in survivors (P<0.05). A significant correlation was seen between serum ferritin and Pediatric Risk of Mortality III (PRISM III) score (r=0.364 P=0.002) and pediatric Sequential Organ Failure Assessment (pSOFA) score (r=0.246 P=0.04) at 48 hours of admission. 54 (77.1%) children were anemic. Serum ferritin levels in children with anemia also had a good predictive ability for poor outcome [AUC: 0.764, 95% CI: 0.634, 0.894].
Conclusions
Serum ferritin levels, within five days of onset of illness, predicted poor outcome in critically ill children with severe sepsis and in children with microcytic anemia.
Keywords: Anemia, C-reactive protein, Infection, Mortality
Contributors
GNS: collected and analyzed data, drafted the manuscript; JGR: concept and designed the study, analyzed the data and supervised the study; NP: managed the cases, analyzed the data and supervised the study; GPS: performed biochemical investigation, analyzed the data and supervised the study. JGR: guarantor of the paper. All authors approved the final version of manuscript and are accountable for all aspects related to the study.
Funding
In part by intramural funds (JIP/Dean(R)/Intramural/Phs 1/2019-20)
Ethics clearance
Institutional ethics committee, JIPMER; No. JIP/IEC/2019/0136, dated June 24, 2019.
Footnotes
Competing interests
None stated.
References
- 1.Carcillo JA. Reducing the global burden of sepsis in infants and children: A clinical practice research agenda. Pediatr Crit Care Med. 2005;6:S157–164. doi: 10.1097/01.PCC.0000161574.36857.CA. [DOI] [PubMed] [Google Scholar]
- 2.Standage SW, Wong HR. Biomarkers for pediatric sepsis and septic shock. Expert Rev Anti Infect Ther. 2011;9:71–9. doi: 10.1586/eri.10.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Horvat CM, Bell J, Kantawala S, et al. C-Reactive protein and ferritin are associated with organ dysfunction and mortality in hospitalized children. Clin Pediatr (Phila) 2019;58:752–60. doi: 10.1177/0009922819837352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Garcia PCR, Longhi F, Branco RG, et al. Ferritin levels in children with severe sepsis and septic shock. Acta Paediatr. 2007;96:1829–31. doi: 10.1111/j.1651-2227.2007.00564.x. [DOI] [PubMed] [Google Scholar]
- 5.Carcillo JA, Sward K, Halstead ES, et al. A systemic inflammation mortality risk assessment contingency table for severe sepsis. Pediatr Crit Care Med. 2017;18:143–50. doi: 10.1097/PCC.0000000000001029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Goldstein B, Giroir B, Randolph A, et al. International Pediatric Sepsis Consensus Conference: Definitions for Sepsis and Organ Dysfunction in Pediatrics. Pediatr Crit Care Med. 2005;6:2–8. doi: 10.1097/01.PCC.0000149131.72248.E6. [DOI] [PubMed] [Google Scholar]
- 7.Pollack MM, Patel KM, Ruttimann UE. PRISM III: An updated pediatric risk of mortality score. Crit Care Med. 1996;24:743–52. doi: 10.1097/00003246-199605000-00004. [DOI] [PubMed] [Google Scholar]
- 8.Matics TJ, Sanchez-Pinto LN. Adaptation and validation of a pediatric sequential organ failure assessment score and evaluation of the sepsis-3 definitions in critically ill children. JAMA Pediatr. 2017;171:e172352. doi: 10.1001/jamapediatrics.2017.2352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation. 2017;135:e927–99. doi: 10.1161/CIR.0000000000000484. [DOI] [PubMed] [Google Scholar]
- 10.Ministry of Health and Family Welfare, Govt of India [Internet]. Guidelines for control of anaemia: National Iron Plus Initiative; 2013. Accessed July 12, 2022. Available from: http://www.pbnrhm.org/docs/iron_plus_guidelines.pdf
- 11.Khan MR, Maheshwari PK, Masood K, et al. Epidemiology and outcome of sepsis in a tertiary care PICU of Pakistan. Indian J Pediatr. 2012;79:1454–8. doi: 10.1007/s12098-012-0706-z. [DOI] [PubMed] [Google Scholar]
- 12.Bellad R, Rao S, Patil VD, et al. Outcome of intensive care unit patients using Pediatric Risk of Mortality (PRISM) score. Indian Pediatr. 2009;46:1091–2. [PubMed] [Google Scholar]
- 13.Kaur G, Vinayak N, Mittal K, et al. Clinical outcome and predictors of mortality in children with sepsis, severe sepsis, and septic shock from Rohtak, Haryana: A prospective observational study. Indian J Crit Care Med. 2014;18:437–41. doi: 10.4103/0972-5229.136072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Ghosh S, Baranwal AK, Bhatia P, et al. Suspecting hyperferritinemic sepsis in iron-deficient population: Do we need a lower plasma ferritin threshold? Pediatr Crit Care Med. 2018;19:e367–73. doi: 10.1097/PCC.0000000000001584. [DOI] [PubMed] [Google Scholar]
- 15.Tonial CT, Costa CAD, Andrades GRH, et al. Prediction of poor outcomes for septic children according to ferritin levels in a middle-income setting. Pediatr Crit Care Med. 2020;21:e259–66. doi: 10.1097/PCC.0000000000002273. [DOI] [PubMed] [Google Scholar]
- 16.Williams V, Menon N, Bhatia P, et al. Serum ferritin predicts neither organ dysfunction nor mortality in pediatric sepsis due to tropical infections. Front Pediatr. 2020;8:607673. doi: 10.3389/fped.2020.607673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Swenson ER, Porcher R, Piagnerelli M. Iron deficiency and infection: another pathway to explore in critically ill patients? Intensive Care Med. 2018;44:2260–62. doi: 10.1007/s00134-018-5438-8. [DOI] [PubMed] [Google Scholar]
- 18.Etzerodt A, Moestrup SK. CD163 and inflammation: Biological, diagnostic, and therapeutic aspects. Antioxid Redox Signal. 2013;18:2352–63. doi: 10.1089/ars.2012.4834. [DOI] [PMC free article] [PubMed] [Google Scholar]